是什么阻碍了我们对视网膜静脉阻塞的理解？ - Suppr

What is Occluding Our Understanding of Retinal Vein Occlusion?

作者信息

Dinah Christiana, Chang Andrew, Lee Junyeop, Li William W, Singh Rishi, Wu Lihteh, Wong David, Saffar Insaf

机构信息

London North West University Healthcare NHS Trust, Northwick Park Hospital, London, UK.

Sydney Retina Clinic, Sydney Eye Hospital, Sydney University, Sydney, Australia.

出版信息

Ophthalmol Ther. 2024 Dec;13(12):3025-3034. doi: 10.1007/s40123-024-01042-6. Epub 2024 Oct 10.

DOI:10.1007/s40123-024-01042-6

PMID:39387960

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11564720/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd2/11564720/16970bc9c552/40123_2024_1042_Fig1_HTML.jpg

相似文献

What is Occluding Our Understanding of Retinal Vein Occlusion?

Ophthalmol Ther. 2024 Dec;13(12):3025-3034. doi: 10.1007/s40123-024-01042-6. Epub 2024 Oct 10.

Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.

Ophthalmology. 2024 Aug;131(8):950-960. doi: 10.1016/j.ophtha.2024.01.029. Epub 2024 Jan 26.

Efficacy and Safety of Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Meta-Analysis.

Ophthalmologica. 2024;247(5-6):355-372. doi: 10.1159/000541662. Epub 2024 Oct 3.

BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and Rationale.

Ophthalmol Sci. 2023 Mar 27;3(3):100302. doi: 10.1016/j.xops.2023.100302. eCollection 2023 Sep.

Intra-Ocular Inflammation and Occlusive Retinal Vasculitis Following Intravitreal Injections of Faricimab: A Case Report.

Ocul Immunol Inflamm. 2024 Dec;32(10):2544-2547. doi: 10.1080/09273948.2024.2361834. Epub 2024 Jun 10.

Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion: 72-Week Results from the BALATON and COMINO Trials.

Ophthalmol Retina. 2025 Mar 17. doi: 10.1016/j.oret.2025.03.005.

Switching to Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: Initial Real-World Efficacy Outcomes.

J Clin Med. 2025 Apr 3;14(7):2454. doi: 10.3390/jcm14072454.

Faricimab: First Approval.

Drugs. 2022 May;82(7):825-830. doi: 10.1007/s40265-022-01713-3.

Emerging clinical evidence of a dual role for Ang-2 and VEGF-A blockade with faricimab in retinal diseases.

Graefes Arch Clin Exp Ophthalmol. 2024 Dec 21. doi: 10.1007/s00417-024-06695-4.

VEGF-Aa and angiopoietin-2 differently affect the barrier formed by retinal endothelial cells.

Exp Eye Res. 2024 Oct;247:110062. doi: 10.1016/j.exer.2024.110062. Epub 2024 Aug 24.

引用本文的文献

Jueling Mingmu decoction combined with ranibizumab for retinal vein occlusion induced macular edema: A randomized controlled clinical trial.

Int Ophthalmol. 2025 Sep 2;45(1):372. doi: 10.1007/s10792-025-03738-5.

本文引用的文献

Multi-risk factors joint prediction model for risk prediction of retinopathy of prematurity.

EPMA J. 2024 May 9;15(2):261-274. doi: 10.1007/s13167-024-00363-7. eCollection 2024 Jun.

Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.

Ophthalmology. 2024 Aug;131(8):950-960. doi: 10.1016/j.ophtha.2024.01.029. Epub 2024 Jan 26.

Evaluating the long-term biological stability of cytokine biomarkers in ocular fluid samples.

BMJ Open Ophthalmol. 2023 Dec 11;8(1):e001346. doi: 10.1136/bmjophth-2023-001346.

Angiopoietin-2 Promotes Mechanical Stress-induced Extracellular Matrix Degradation in Annulus Fibrosus Via the HIF-1α/NF-κB Signaling Pathway.

Orthop Surg. 2023 Sep;15(9):2410-2422. doi: 10.1111/os.13797. Epub 2023 Jul 21.

High Variation in Inner Retinal Reflectivity Predicts Poor Visual Outcome in Patients With Central Retinal Vein Occlusion: SCORE2 Report 21.

Transl Vis Sci Technol. 2023 Jun 1;12(6):21. doi: 10.1167/tvst.12.6.21.

Foveal Eversion is Associated with High Persistence of Macular Edema and Visual Acuity Deterioration in Retinal Vein Occlusion.

Ophthalmol Ther. 2023 Aug;12(4):2157-2169. doi: 10.1007/s40123-023-00734-9. Epub 2023 Jun 9.

SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion.

Ophthalmology. 2023 Oct;130(10):1066-1072. doi: 10.1016/j.ophtha.2023.05.023. Epub 2023 May 21.

Changes in Aqueous and Vitreous Inflammatory Cytokine Levels in Retinal Vein Occlusion: A Systematic Review and Meta-analysis.

J Vitreoretin Dis. 2019 Oct 31;4(1):36-64. doi: 10.1177/2474126419880391. eCollection 2020 Jan-Feb.

Update on Retinal Vein Occlusion.

Asia Pac J Ophthalmol (Phila). 2023;12(2):196-210. doi: 10.1097/APO.0000000000000598. Epub 2023 Feb 14.

Red Blood Cells: A Newly Described Partner in Central Retinal Vein Occlusion Pathophysiology?

Int J Mol Sci. 2023 Jan 5;24(2):1072. doi: 10.3390/ijms24021072.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

What is Occluding Our Understanding of Retinal Vein Occlusion?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

What is Occluding Our Understanding of Retinal Vein Occlusion?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献